IRCT20200708048051N3
Recruiting
Phase 3
Clinical Trial of Evaluation of the effects of intranasal desmopressin on intraoperative blood loss and quality of the surgical field during open rhinoplasty:
Rasht University of Medical Sciences0 sites120 target enrollmentTBD
ConditionsRhinoplasty surgery.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Rhinoplasty surgery.
- Sponsor
- Rasht University of Medical Sciences
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients 18 to 40 years old who are candidates for rhinoplasty
Exclusion Criteria
- •People with abnormal coagulation tests
- •People with a history of cardiovascular disease
- •Patients with coagulation diseases
- •People taking anticoagulants
- •Patients with brain diseases, hypertension and diabetes
- •Pregnant women
- •History of seizures
- •Consumption of herbal supplements and vitamin E.
- •Corticosteroid users in the last two weeks
- •Consumers of diuretics
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effects of intranasal desmopressin on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgeryIRCT20200708048051N2Rasht University of Medical Sciences120
Completed
N/A
A clinical study for evaluating the effects of intake of test food on cognitive function: A randomized, double-blind, placebo-controlled, parallel-group comparative methodHealthy adultJPRN-UMIN000052060EP Mediate Co., Ltd.150
Recruiting
Phase 1
A clinical trial to evaluate the usefulness of intraoperative intestinal blood f low assessment using anendoscope for the gastrointestinal tractColorectal CancerJPRN-jRCTs032220010Matsubara Hisahiro40
Withdrawn
Phase 3
Paracetamol RCT - Oral Vs Intravenous antidotesiver cell injury in acetaminophen overdose.SLCTR/2015/031South Asian Clinical Toxicology Research Collaboration (SACTRC)
Completed
Phase 3
Evaluation of the effect of intracavernous stem cell injection on the treatment of erectile dysfunction in diabetic patientsErectile dysfunction.Male erectile dysfunctionIRCT20190517043609N1Kerman University of Medical Sciences20